HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation (original) (raw)
References
Gabuzda, D.H. et al. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol.66, 6489–6495 (1992). CASPubMedPubMed Central Google Scholar
Madani, N. & Kabat, D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol.72, 10251–10255 (1998). CASPubMedPubMed Central Google Scholar
Simon, J.H., Gaddis, N.C., Fouchier, R.A. & Malim, M.H. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med.4, 1397–1400 (1998). ArticleCAS Google Scholar
Sheehy, A.M., Gaddis, N.C., Choi, J.D. & Malim, M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature418, 646–650 (2002). ArticleCAS Google Scholar
Gaddis, N.C., Chertova, E., Sheehy, A.M., Henderson, L.E. & Malim, M.H. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions. J. Virol.77, 5810–5820 (2003). ArticleCAS Google Scholar
Ochsenbauer, C., Wilk, T. & Bosch, V. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1. J. Gen. Virol.78, 627–635 (1997). ArticleCAS Google Scholar
von Schwedler, U., Song, J., Aiken, C. & Trono, D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol.67, 4945–4955 (1993). CASPubMedPubMed Central Google Scholar
Courcoul, M. et al. Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J. Virol.69, 2068–2074 (1995). CASPubMedPubMed Central Google Scholar
Simon, J.H. & Malim, M.H. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol.70, 5297–5305 (1996). CASPubMedPubMed Central Google Scholar
Dettenhofer, M., Cen, S., Carlson, B.A., Kleiman, L. & Yu, X.F. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. J. Virol.74, 8938–8945 (2000). ArticleCAS Google Scholar
Goncalves, J., Korin, Y., Zack, J. & Gabuzda, D. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol.70, 8701–8709 (1996). CASPubMedPubMed Central Google Scholar
Teng, B., Burant, C.F. & Davidson, N.O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science260, 1816–1819 (1993). ArticleCAS Google Scholar
Harris, R.S., Petersen-Mahrt, S.K. & Neuberger, M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell10, 1247–1253 (2002). ArticleCAS Google Scholar
Liu, H. et al. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol.69, 7630–7638 (1995). CASPubMedPubMed Central Google Scholar
Khan, M.A. et al. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. J. Virol.75, 7252–7265 (2001). ArticleCAS Google Scholar
Lecossier, D., Bouchonnet, F., Clavel, F. & Hance, A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science300, 1112 (2003). ArticleCAS Google Scholar
Zhang, H. et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature424, 94–98 (2003). ArticleCAS Google Scholar
Mangeat, B., Turelli, P., Caron, G., Friedli, L.P. & Trono, D. Broad antiretroviral defense by human Apobec3G through lethal editing of nascent reverse transcripts. Nature424, 99–103 (2003). ArticleCAS Google Scholar
Harris, R.S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell113, 803–809 (2003). ArticleCAS Google Scholar
Mariani, R. et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell114, 21–31 (2003). ArticleCAS Google Scholar
Oberste, M.S. & Gonad, M.A. Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes6, 95–102 (1992). ArticleCAS Google Scholar
Page, K.A., Landau, N.R. & Littman, D.R. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol.64, 5270–5276 (1990). CASPubMedPubMed Central Google Scholar
Madani, N. & Kabat, D. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein. J. Virol.74, 5982–5987 (2000). ArticleCAS Google Scholar
Simon, J.H., Sheehy, A.M., Carpenter, E.A., Fouchier, R.A. & Malim, M.H. Mutational analysis of the human immunodeficiency virus type 1 Vif protein. J. Virol.73, 2675–2681 (1999). CASPubMedPubMed Central Google Scholar
Garrett, E.D., Tiley, L.S. & Cullen, B.R. Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J. Virol.65, 1653–1657 (1991). CASPubMedPubMed Central Google Scholar
Gluschankof, P., Mondor, I., Gelderblom, H.R. & Sattentau, Q.J. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology230, 125–133 (1997). ArticleCAS Google Scholar
Verma, R. & Deshaies, R.J. A proteasome howdunit: the case of the missing signal. Cell101, 341–344 (2000). ArticleCAS Google Scholar
Kamura, T. et al. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev.12, 3872–3881 (1998). ArticleCAS Google Scholar
Iwai, K. et al. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA96, 12436–12441 (1999). ArticleCAS Google Scholar
Schubert, U. et al. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol.72, 2280–2288 (1998). CASPubMedPubMed Central Google Scholar
Margottin, F. et al. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell1, 565–574 (1998). ArticleCAS Google Scholar
Desrosiers, R.C. et al. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol.72, 1431–1437 (1998). CASPubMedPubMed Central Google Scholar
Barnes, W.M. PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates. Proc. Natl. Acad. Sci. USA91, 2216–2220 (1994). ArticleCAS Google Scholar
Sambrook, J., Fritsch, E.F. & Maniatis, T. In vitro amplification of DNA by the polymerase chain reaction. in Molecular Cloning: A Laboratory Manual 14.5–14.34 (Cold Spring Harbor Laboratory Press, New York, 1989). Google Scholar
Helseth, E. et al. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol.64, 2416–2420 (1990). CASPubMedPubMed Central Google Scholar
Page, K.A., Stearns, S.M. & Littman, D.R. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J. Virol.66, 524–533 (1992). CASPubMedPubMed Central Google Scholar
Platt, E.J., Kuhmann, S.E., Rose, P.P. & Kabat, D. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region. J. Virol.75, 12266–12278 (2001). ArticleCAS Google Scholar
Marin, M., Tailor, C.S., Nouri, A. & Kabat, D. Sodium-dependent neutral amino acid transporter type 1 is an auxiliary receptor for baboon endogenous retrovirus. J. Virol.74, 8085–8093 (2000). ArticleCAS Google Scholar
Klippel, A., Escobedo, J.A., Hirano, M. & Williams, L.T. The interaction of small domains between the subunits of phosphatidylinositol 3-kinase determines enzyme activity. Mol. Cell. Biol.14, 2675–2685 (1994). ArticleCAS Google Scholar
Tailor, C.S., Nouri, A., Lee, C.G., Kozak, C. & Kabat, D. Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc. Natl. Acad. Sci. USA96, 927–932 (1999). ArticleCAS Google Scholar